Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,418
+$808 QoQ
Shares Held
25
-3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,630
of 1,746 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tidemark, LLC holds $636,619 across 20 Biotechnology names. VRTX ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
646 | $402,806 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
4,340 | $73,649 | |
| 3 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,088 | $45,336 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
288 | $22,541 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
280 | $15,271 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
25 | $12,418 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
86 | $3,354 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,418 | 25 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $11,610 | 26 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $10,427 | 23 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,965 | 28 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $10,684 | 24 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,363 | 9 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $3,624 | 9 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,185 | 9 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,218 | 9 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,762 | 9 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,662 | 9 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||